Male birth control pill enters human testing
NCT ID NCT06542237
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new daily pill called YCT-529 for male contraception. It involves 88 healthy men who have decided not to have children. The pill is taken for 28, 90, or 180 days to check its safety, side effects, and how well it works. This is an early step toward giving men a daily birth control option.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
YCT-529 (a daily oral pill for male contraception)
What this could lead to
If successful, this could lead to a new, non-hormonal daily birth control pill for men, giving couples more options.
What could go wrong
This is an early-phase trial with only 88 men, so it may not prove safe or effective enough. Side effects or lack of reliable contraception are possible risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALE CONTRACEPTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Zealand Clinical Research (NZCR)
RECRUITINGGrafton, Auckland, 1010, New Zealand
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••